Should home-based HIV testing and counseling services be offered periodically in programs of ARV treatment as prevention? A case study in Likoma (Malawi).

Should home-based HIV testing and counseling services be offered periodically in programs of ARV treatment as prevention? A case study in Likoma (Malawi).
复制标题

是否应定期在ARV治疗计划中定期提供基于家庭的艾滋病毒测试和咨询服务? Likoma(马拉维)的案例研究。

DOI:
10.1007/s10461-012-0365-0
复制
发表时间:
2013-07
期刊:
影响因子:
4.4
通讯作者:
Kohler, Hans-Peter
Kohler, Hans-Peter
中科院分区:
医学2区
文献类型:
--
作者:
Helleringer, Stephane;Mkandawire, James;Reniers, Georges;Kalilani-Phiri, Linda;Kohler, Hans-Peter

文献摘要

参考文献

被引文献

相似文献

为了降低艾滋病毒的发病率,以使用抗逆转录病毒药物为中心的预防计划需要扩大艾滋病毒检测和咨询(HTC)。基于家庭的家庭保健服务(HBHTC)增加了家庭保健服务的覆盖面,但HBHTC只在一次性活动中进行了评估。在HBHTC首次运动(“第一轮”)两年后,我们在Likoma(马拉维)进行了另一次HBHTC运动(“第二轮”)。在第二轮中,妇女的HBHTC参与率增加(从74%增加到83%,p<0.01)。HBHTC招募了新的客户,特别是25岁以上的客户。在第二轮之后,只有6.9%的妇女和15.9%的男子仍然没有得到HBHTC的帮助。在第2轮中,第1轮中艾滋病毒呈阴性的客户的艾滋病毒感染率较低(0.7%),但在第2轮中首次检测的妇女的感染率较高(42.8%)。在第二轮期间,每例新诊断感染的成本大幅增加。定期开展HBHTC运动可以进一步提高HTC,但需要采取补充干预措施,招募HBHTC未覆盖的个人。
To reduce HIV incidence, prevention programs centered on the use of antiretrovirals require scaling-up HIV testing and counseling (HTC). Home-based HTC services (HBHTC) increase HTC coverage, but HBHTC has only been evaluated during one-off campaigns. Two years after an initial HBHTC campaign (“round 1”), we conducted another HBHTC campaign (“round 2”) in Likoma (Malawi). HBHTC participation increased during round 2 among women (from 74% to 83%, p<0.01). New HBHTC clients were recruited, especially at ages 25 and older. Only 6.9% of women but 15.9% of men remained unreached by HBHTC after round 2. HIV prevalence during round 2 was low among clients who were HIV-negative during round 1 (0.7%), but high among women who first tested during round 2 (42.8%). The costs per newly diagnosed infection increased significantly during round 2. Periodically conducting HBHTC campaigns can further increase HTC, but supplementary interventions to enroll individuals not reached by HBHTC are needed.
DOI: 10.1371/journal.pone.0009538
发表时间: 2010-03-04
期刊: PloS one
影响因子: 3.7
作者:
Losina E;Bassett IV;Giddy J;Chetty S;Regan S;Walensky RP;Ross D;Scott CA;Uhler LM;Katz JN;Holst H;Freedberg KA
通讯作者: Freedberg KA
DOI: 10.1097/qai.0b013e3181ced126
发表时间: 2010-07
期刊: Journal of acquired immune deficiency syndromes (1999)
影响因子: --
作者:
Grabbe KL;Menzies N;Taegtmeyer M;Emukule G;Angala P;Mwega I;Musango G;Marum E
通讯作者: Marum E
DOI: 10.1371/journal.pmed.0030238
发表时间: 2006-07
期刊: PLoS medicine
影响因子: 15.8
作者:
Corbett EL;Dauya E;Matambo R;Cheung YB;Makamure B;Bassett MT;Chandiwana S;Munyati S;Mason PR;Butterworth AE;Godfrey-Faussett P;Hayes RJ
通讯作者: Hayes RJ
DOI: 10.1097/00002030-200303280-00012
发表时间: 2003-03-28
期刊: AIDS
影响因子: 3.8
作者:
Allen, S;Meinzen-Derr, L;Haworth, A
通讯作者: Haworth, A
DOI: 10.1111/j.1365-3156.2007.01923.x
发表时间: 2007-11-01
影响因子: 3.3
作者:
Matovu, Joseph K. B.;Makumbi, Fredrick E.
通讯作者: Makumbi, Fredrick E.